期刊
MOLECULES
卷 25, 期 9, 页码 -出版社
MDPI
DOI: 10.3390/molecules25092163
关键词
glycogen synthase kinase-3 beta (GSK-3 beta); 1H-indazole-3-carboxamide core (INDZ); imidazo[1; 5-a]pyridine-1-carboxamide core (IMID 1); imidazo[1; 5-a]pyridine-3-carboxamide core (IMID 2); CNS permeability; molecular docking; molecular dynamics (MD); quantum mechanics (QM); X-ray crystallography; NMR characterization
The interest of research groups and pharmaceutical companies to discover novel GSK-3 beta inhibitors has increased over the years considering the involvement of this enzyme in many pathophysiological processes and diseases. Along this line, we recently reported on 1H-indazole-3-carboxamide (INDZ) derivatives 1-6, showing good GSK-3 beta inhibition activity. However, they suffered from generally poor central nervous system (CNS) permeability. Here, we describe the design, synthesis, and in vitro characterization of novel imidazo[1,5-a]pyridine-1-carboxamide (IMID 1) and imidazo[1,5-a]pyridine-3-carboxamide (IMID 2) compounds (7-18) to overcome such liability. In detail, structure-based approaches and fine-tuning of physicochemical properties guided the design of derivatives 7-18 resulting in ameliorated absorption, distribution, metabolism, and excretion (ADME) properties. A crystal structure of 16 in complex with GSK-3 beta enzyme (PDB entry 6Y9S) confirmed the in silico models. Despite the nanomolar inhibition activity, the new core compounds showed a reduction in potency with respect to INDZ derivatives 1-6. In this context, Molecular Dynamics (MD) and Quantum Mechanics (QM) based approaches along with NMR investigation helped to rationalize the observed structure activity relationship (SAR). With these findings, the key role of the acidic hydrogen of the central core for a tight interaction within the ATP pocket of the enzyme reflecting in good GSK-3 beta affinity was demonstrated.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据